Loading...
Market
Who will be PfizerForAll platform's first major competitor by June 30, 2025?
2
Resolution / Starting Odds
Moderna • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Other • 25%
Official announcement from competing company or reputable news sources
Story
Pfizer Launches PfizerForAll to Enhance Healthcare Access
Aug 27, 2024, 11:07 AM
Pfizer has launched a new digital platform, PfizerForAll, aimed at simplifying access to healthcare. This direct-to-consumer initiative is designed to improve access to treatments for conditions such as migraines, COVID-19, and respiratory illnesses. The platform integrates various services, including diagnosis, prescribing, vaccine scheduling, and prescription fulfillment, with key partners like Alto Pharmacy. This move aligns with similar efforts in the industry, following the launch of LillyDirect earlier this year.
View original story
Similar markets
Johnson & Johnson • 25%
Merck • 25%
AstraZeneca • 25%
Other • 25%
Alto Pharmacy • 25%
Telehealth provider A • 25%
Telehealth provider B • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Biogen • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Biotech company • 25%
Pharmaceutical company • 25%
Medical device company • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Yes • 50%
No • 50%
Migraine medication • 25%
COVID-19 medication • 25%
Flu medication • 25%
Respiratory illness medication • 25%
Biogen • 25%
Roche • 25%
Novartis • 25%
Other • 25%
None • 25%
1 new category • 25%
2 to 3 new categories • 25%
More than 3 new categories • 25%
Pfizer has the largest market share • 25%
Moderna has the largest market share • 25%
Novavax has the largest market share • 25%
Other companies have the largest market share • 25%